Did Generic Clopidogrel Commercialization Affect Trends of ER Consultations and Hospitalizations in the Population Treated with Clopidogrel?-Reference-Cited by-同舟云学术

Did Generic Clopidogrel Commercialization Affect Trends of ER Consultations and Hospitalizations in the Population Treated with Clopidogrel?

Published:2019-05-10 Issue:8 Volume:36 Page:759-768
ISSN:1170-229X
Container-title:Drugs & Aging
language:en
Short-container-title:Drugs Aging

Author:

Leclerc Jacinthe,Blais Claudia,Rochette Louis,Hamel Denis,Guénette Line,Poirier Paul

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Geriatrics and Gerontology

Link

http://link.springer.com/content/pdf/10.1007/s40266-019-00679-4.pdf

Reference43 articles.

1. United States Patent and Trademark Office. General information concerning patents. https://www.uspto.gov/patents-getting-started/general-information-concerning-patents . Accessed 21 Nov 2018.

2. Office de la propriété intellectuelle du Canada. Base de données sur les brevets canadiens. http://brevets-patents.ic.gc.ca/opic-cipo/cpd/fra/aide/contenu/aide_informations_generales.html . Accessed 3 Apr 2015.

3. European Patent Office. Biotechnology patents at the EPO. http://www.epo.org/news-issues/issues/biotechnology-patents.html . Accessed 28 Aug 2017.

4. Leclerc J. Surveillance des consultations à l’urgence et des hospitalisations chez les utilisateurs de médicaments génériques et originaux en cardiologie, au Québec. 2017; Université Laval (448 pages).

5. Sanofi-Aventis Canada Inc. Monographie de produit Plavix (clopidogrel). http://products.sanofi.ca/fr/plavix.pdf . Accessed 20 Oct 2016.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of ionic liquids and deep eutectic solvents on the enantiomeric separation of clopidogrel by cyclodextrin-electrokinetic chromatography. Quantitative analysis in pharmaceutical formulations using tetrabutylammonium l-aspartic acid combined with carboxymethyl-γ-cyclodextrin;Microchemical Journal;2021-12

2. Corporate Lobbyists: Open Season on Academic Health Science?;Canadian Journal of Cardiology;2021-02

3. Public Health Outcomes May Differ After Switching from Brand-Name to Generic Angiotensin II Receptor Blockers;Drugs in R&D;2020-04-27

4. Are Generic Drugs Used in Cardiology as Effective and Safe as their Brand-name Counterparts? A Systematic Review and Meta-analysis;Drugs;2020-04-11